Hong Kong Innovative Pharmaceuticals ETFs are exchange-traded funds that track companies related to innovative pharmaceuticals in the Hong Kong stock market. Among them, the Hang Seng Healthcare ETF is an ETF that tracks the Hang Seng Healthcare Index, which includes companies related to the healthcare sector in the Hong Kong stock market. On the other hand, the HK Innovative Medicine ETF is an ETF that covers a broader range of innovative medicine sectors, including but not limited to the healthcare sector. Specifically, the portfolio of a Hong Kong Innovative Pharmaceuticals ETF may include innovative pharmaceuticals-related companies such as WuXi AppTec, WuXi Biologics, Baizi ShenZhou, Jingdong Health, Sinopharm, AliHealth, Henson Pharmaceuticals and Cinda Biotechnology. These ETFs are designed to provide investors with the opportunity to participate in the innovative drug space in Hong Kong stocks.